Earnings, Q4 FY2025AnnualMar 6, 2026Clinical revenue surged 68% year-over-year, fueling scale-up and recurring revenue growth.Call transcriptCall transcriptAnnual reportAnnual reportSlidesSlidesInterim reportInterim report
Earnings, Q2 FY2025Aug 28, 2025Clinical revenue surged 60% year-over-year, driving a 58% order book increase and strong outlook.Call transcriptCall transcriptSlidesSlidesInterim reportInterim report
Earnings, Q4 FY2024AnnualMar 7, 2025Clinical market focus and major deals drove strong growth, with break-even targeted for 2024.Call transcriptCall transcriptAnnual reportAnnual reportSlidesSlidesInterim reportInterim report
Earnings, Q2 FY2024Aug 29, 2024Strong revenue growth and major European contracts position the company for future profitability.Call transcriptCall transcriptSlidesSlidesInterim reportInterim report
Earnings, Q4 FY2023AnnualMar 7, 2024Call transcriptCall transcriptAnnual reportAnnual reportAnnual reportAnnual reportSlidesSlidesInterim reportInterim report
Earnings, Q2 FY2023Aug 25, 2023Call transcriptCall transcriptSlidesSlidesInterim reportInterim report
Earnings, Q4 FY2022AnnualMar 2, 2023Call transcriptCall transcriptAnnual reportAnnual reportSlidesSlidesInterim reportInterim report